News

Vertex: Latest Casgevy Data Highlights Efficacy Amid Slow Commercial Launch
Vertex Pharmaceuticals Incorporated remains a top Buy with a strong cystic fibrosis franchise, innovative pipeline, and cell therapies. Click for my VRTX update.
Investing Snacks6d
Vertex Eyes Growth With CF and Pain Drug Innovations
PGIM Jennison Health Sciences Fund’s Q1 2025 letter highlights mixed sector returns, with Vertex Pharmaceuticals in focus.
Yahoo Finance1d
Trump tariffs live updates: Canada, EU, Mexico set to be hit with 30% ...
Yahoo Finance is chronicling the latest news and updates on Trump's tariffs.